SensArs Neuroprosthetics is a pioneering brand that specializes in developing bionic prosthetics and neuroprosthetic systems. With a strong focus on innovation and cutting-edge technology, SensArs has received a significant boost with a €3 million grant from the European Union's Horizon Research and Innovation program. This grant will enable them to further develop and test their groundbreaking neuroprosthetic system.

Consistently recognized for their innovation, SensArs has been named one of Business Worldwide Magazine's Top 20 Most Innovative Companies to Watch in 2022. Additionally, they have received FDA Breakthrough Device Designation, highlighting their commitment to providing sensory feedback for individuals with limb loss to improve prosthesis function. SensArs boasts deep partnerships with prestigious institutions, clinics, and accelerators, and has been honored with numerous global awards for their breakthrough technology.

Their research has been featured in leading publications such as Nature Medicine and Annals of Neurology. Led by CEO Francesco Petrini, an MIT Technology Review Top Innovator Under 35, SensArs is at the forefront of pioneering neurotechnology. With their unique technology, SensArs aims to revive the brain-body connection, eliminate pain, and create new possibilities in the field of neurotech, ranging from brain-computer interfaces to obesity and depression treatment.

Experience the transformative benefits of SensArs' sensory feedback system and feel whole again. Contact them today to learn more about their groundbreaking solutions